News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Syrrx, Inc. Announces Research Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) And Receives First Success Payment


10/19/2005 5:11:32 PM

Syrrx, Inc., a next generation structure based drug discovery company, today announced the receipt of the first success-based milestone payment from Biogen Idec (NASDAQ:BIIB) based on a collaborative agreement executed on December 16, 2003 between the two parties. The collaboration applies Syrrx's expertise in high-throughput crystallization of proteins across multiple Biogen Idec drug targets.

Read at BioSpace.com

Related News

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES